[1]彭炳贤,罗子清,张 溪.白虎加人参汤联合复方薤白胶囊治疗重症肺部感染疗效研究[J].陕西中医,2021,(12):1692-1695.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.009]
　PENG Bingxian,LUO Ziqing,ZHANG Xi.Clinical research on Baihu Renshen decoction combined with compound Xiebai capsule in treatment of severe pulmonary infection[J].,2021,(12):1692-1695.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.009]
点击复制

白虎加人参汤联合复方薤白胶囊治疗重症肺部感染疗效研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年12期
页码:
1692-1695
栏目:
临床研究
出版日期:
2021-12-05

文章信息/Info

Title:
Clinical research on Baihu Renshen decoction combined with compound Xiebai capsule in treatment of severe pulmonary infection
作者:
彭炳贤1; 罗子清2; 张 溪3
(1.广州中医药大学第二临床医学院,广东 广州 510006; 2.广州中医药大学,广东 广州 510405; 3.广东省中医院,广东 广州 510210)
Author(s):
PENG Bingxian; LUO Ziqing; ZHANG Xi
(The Second Clinical Medical College of Guangzhou University of Traditional Chinese Medicine,Guangzhou 510006,China)
关键词:
重症肺部感染;  白虎加人参汤;  复方薤白胶囊;  可溶性髓样细胞触发性受体-1;  肺表面活性蛋白D
Keywords:
Severe pulmonary infection;  Baihu Renshen decoction;  Compound Xiebai capsule;  Soluble triggering receptor expressed on myeloid cells-1;  Pulmonary surfactant protein D
分类号:
R 563
DOI:
DOI:10.3969/j.issn.1000-7369.2020.12.009
文献标志码:
A
摘要:
目的:探讨白虎加人参汤联合复方薤白胶囊治疗重症肺部感染疗效及对血清可溶性髓样细胞触发性受体-1(sTREM-1)、肺表面活性蛋白D(SP-D)的影响。方法:选择重症肺部感染患者103例,随机分为对照组、观察组。对照组采用常规西医加复方薤白胶囊治疗,观察组在对照组基础上加用白虎加人参汤。治疗后,比较两组临床疗效、中医证候积分、血清sTREM-1和SP-D水平变化,使用临床肺部感染评分(CPIS)、急性生理和慢性健康状况Ⅱ(APACHE Ⅱ)评分评价肺部感染、健康状况。结果:治疗后,观察组总有效率94.23%高于对照组的80.39%(P<0.05)。治疗后,观察组各中医证候积分低于对照组,差异有统计学意义(均P<0.05)。治疗后,观察组sTREM-1、SP-D水平低于对照组,差异有统计学意义(均P<0.05)。治疗后,观察组CPIS评分、APACHE Ⅱ评分低于对照组,差异有统计学意义(均P<0.05)。结论:白虎加人参汤联合复方薤白胶囊治疗重症肺部感染临床疗效较好,可改善患者症状,减轻肺部感染程度。
Abstract:
Objective:To evaluate clinical efficacy of Baihu Renshen decoction combined with compound Xiebai capsule in treatment of severe pulmonary infection and its influence on levels of soluble triggering receptor expressed on myeloid cells-1(sTREM-1)and pulmonary surfactant protein D(SP-D)of patients.Methods:103 patients with severe pulmonary infection were randomly divided into control group and observation group.The control group were treated with conventional western medicine and compound Xiebai capsule,and the observation group were additionally given Baihu Renshen decoction on the basis of the control group.After treatment,clinical efficacy,scores of TCM syndromes and levels of serum sTREM-1 and SP-D were compared between the two groups.Clinical pulmonary infection score(CPIS),acute physiology and chronic health evaluation Ⅱ(APACHE Ⅱ)were applied to evaluate the pulmonary infection and health status of the two groups.Results:After treatment,the effective rate of clinical treatment in the observation group was 94.23% was higher than 80.39% in the control group.After treatment,the scores of TCM syndromes of the observation group were lower than those in the control group(all P<0.05).After treatment,the levels of serum sTREM-1 and SP-D were lower in the observation group than those in the control group(all P<0.05).After treatment,the scores of CPIS and APACHE Ⅱ of the observation group were lower than those of the control group(all P<0.05).Conclusion:Baihu Renshen decoction combined with compound Xiebai capsule has obvious clinical efficacy in the treatment of severe pulmonary infection, improve syndromes,reduce degree of pulmonary infection.

参考文献/References:

[1] 贾明雅,郑喜胜,董照刚,等.重症肺炎合并肺部感染患者胸部CT征象及其诊断价值研究[J].中国CT和MRI杂志,2021,19(5):33-34.
[2] 董 亮,张秀红,梁锋鸣,等.髓样细胞可溶性触发受体-1在呼吸机相关性肺炎预后评估中的价值研究[J].中华急诊医学杂志,2018,27(1):93-98.
[3] 秦 妮,段亚楠,张 颖,等.急性呼吸窘迫综合征患者血清CC-16、SP-D水平变化及临床意义[J].山东医药,2019,59(34):22-25.
[4] 贺小龙,罗科举.清金化痰汤辅佐抗生素治疗脑卒中并肺部感染的临床疗效及安全性观察[J].贵州医药,2020,44(9):1444-1445.
[5] 林燕林,张星星,高志凌,等.清热化痰法联合亚胺培南-西司他丁钠对重症肺部感染患者IL-6、TNF-α水平的影响[J].陕西中医,2020,41(7):891-893.
[6] 奚肇庆,陈晟毅.复方薤白胶囊联合常规疗法对AECOPD痰热郁肺证患者肺功能影响的研究——附30例临床资料[J].江苏中医药,2017,49(6):23-25.
[7] 王 敏,闫 蕾.白虎承气汤治疗重症肺炎疗效及其作用机制研究[J].陕西中医,2019,40(12):1693-1696.
[8] 陈云峰.关于《中国成人社区获得性肺炎诊断和治疗指南(2016年版)》中重症肺炎诊断标准的商榷[J].中华结核和呼吸杂志,2017,40(8):639.
[9] 朱文锋.中医诊断学[M].北京:人民卫生出版社,2011:311.
[10] 沈 锋,吴彦其,王亚辉,等.CPIS评分指导ICU细菌性重症肺炎患者治疗能减少抗菌药物使用持续时间及使用频度[J].中华危重病急救医学,2019,31(5):556-561.
[11] 刘 纪,张生雷,茅一萍,等.ASIS和APACHE Ⅱ评分对重症患者病情严重程度评估作用的研究[J].中华医院感染学杂志,2018,28(8):1195-1198.
[12] 阎 丽,张春霞,孙希蓉,等.β-内酰胺类抗菌药物联合胸腺肽治疗慢阻肺并发肺部感染的临床疗效[J].中华医院感染学杂志,2021,31(10):1517-1521.
[13] 曾余丰,葛金林,蒋龙翔.脑钠肽联合临床肺部感染评分对老年重症肺炎患者早期病情评估的价值[J].浙江医学,2020,42(20):2205-2208.
[14] 贾晶晶,殷 娟,焦飞燕.重症监护室老年患者肺部感染细菌耐药性研究[J].陕西医学杂志,2019,48(7):890-893.
[15] 王 兴,杜晓刚.中医外感热病理论溯源[J].中医学报,2020,35(2):232-235.
[16] 杨勤军,张星星,李泽庚,等.论唐宗海《血证论》辨治内伤咳嗽思想[J].中华中医药杂志,2018,33(9):3799-3801.
[17] 马 鹏,李群堂,成茂源,等.薛生白《湿热病篇》以六经辨析湿热病规律探究[J].世界科学技术-中医药现代化,2019,21(5):1002-1006.
[18] 熊兴江.基于临床重症病例及中西医结合解读《伤寒论》白虎加人参汤方证及其退热、升压、纠正高渗、降糖的治疗急危重症体会[J].中国中药杂志,2019,44(18):3861-3868.
[19] 赵 微,刘小静,曲 萌.无创正压机械通气配合参芪扶正注射液治疗对重症肺炎呼吸衰竭患者血气指标及血清sTREM-1、SP-D水平的影响[J].中国中医急症,2021,30(2):265-267,292.
[20] 刘景祎,郭红娜.针刺五泉穴结合穴位按摩在脑出血后吞咽障碍并发肺部感染患者中的应用效果[J].陕西中医,2019,40(1):125-127.
[21] 刘 洁,王 斐,杨 侠,等. 黄连解毒汤对重度颅脑损伤合并肺部感染患者血气指标和炎症因子影响分析[J].陕西中医,2020,41(3):318-320,349.

相似文献/References:

[1]陈泽瑶,陈家祈,张 琦,等.白虎加人参汤治疗2型糖尿病Meta分析[J].陕西中医,2024,(7):989.[doi:DOI:10.3969/j.issn.1000-7369.2024.07.029]
[2]刘 清,王 芳,张淑娟,等.白虎加人参汤对2型糖尿病大鼠抗氧化应激作用及机制研究[J].陕西中医,2024,(9):1166.[doi:DOI:10.3969/j.issn.1000-7369.2024.09.003]
　LIU Qing,WANG Fang,ZHANG Shujuan,et al.Effect and mechanism of Baihu jia Renshen decoction on anti-oxidative stress in type 2 diabetic rats[J].,2024,(12):1166.[doi:DOI:10.3969/j.issn.1000-7369.2024.09.003]

备注/Memo

备注/Memo:
基金项目:国家科技重大专项(2017ZX10305501-006)
更新日期/Last Update: 2021-12-09